Myriad Genetics | MYGN - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Agilent USD 37.86B 3.64B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Bio-Rad Laboratories USD 6.35B 1.86B 2026-04
Bruker USD 7.16B 2.23B 2025-12
Danaher USD 130.07B 1.61B 2026-04
Illumina USD 19.95B 670M 2026-04
J&J USD 561.65B 17.5B 2026-04
Mettler Toledo International USD 28.48B 3.19B 2025-12
Myriad Genetics USD 575M 98M 2025-12
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Quest Diagnostics USD 22.04B 348M 2026-04
Quidel USD 1.99B 66M 2025-12
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Standard Biotools USD 492M 5M 2025-12
Thermo Fisher Scientific USD 177.96B 4.7B 2026-04
Veracyte USD 3.33B 627M 2025-12
Waters USD 22.61B 5.25B 2025-12